These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 13361968)

  • 21. Epidemiologic significance of isoniazid resistant Mycobacteria tuberculosis with defective virulence.
    MEISSNER G
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1956; 116(2):125-31. PubMed ID: 13373709
    [No Abstract]   [Full Text] [Related]  

  • 22. Characteristics of African Mycobacterium tuberculosis. Constancy of drug susceptibility in laboratory animals.
    Zykov MP; Roulet H; Gaya N
    Am Rev Respir Dis; 1973 Jul; 108(1):93-100. PubMed ID: 4123739
    [No Abstract]   [Full Text] [Related]  

  • 23. [Porphyrin content and catalase activities of isoniazid-resistant strains of mycobacteria. Report II].
    TOIDA I; SAITO C
    Kekkaku; 1960 Apr; 35():292-5. PubMed ID: 13838662
    [No Abstract]   [Full Text] [Related]  

  • 24. [Analysis of catalase and peroxidase activity of tubercle bacilli sensitive and resistant to INH].
    Litwin B; Srednicka-Zajac D; Przemyska B
    Gruzlica; 1968 Jun; 36(6):505-8. PubMed ID: 4970097
    [No Abstract]   [Full Text] [Related]  

  • 25. Impact of isoniazid resistance on virulence of global and south Indian clinical isolates of Mycobacterium tuberculosis.
    Ameeruddin NU; Luke Elizabeth H
    Tuberculosis (Edinb); 2014 Dec; 94(6):557-63. PubMed ID: 25270728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Catalase and peroxidase activity of INH-sensitive and INH-resistant tubercle bacilli.
    Litwin B; Srednicka-Zajac D; Przemyska B
    Pol Med J; 1969; 8(4):879-82. PubMed ID: 4998817
    [No Abstract]   [Full Text] [Related]  

  • 27. Inhibition of mycobacterial catalase activity by isoniazid.
    WOODS CJ
    Am Rev Respir Dis; 1961 Dec; 84():913-5. PubMed ID: 14008239
    [No Abstract]   [Full Text] [Related]  

  • 28. [Virulence of INH-resistant tubercle bacilli to the human body. I. Infectiousness of INH-resistant tubercle bacilli].
    Murata A
    Kekkaku; 1967 Sep; 42(9):343-8. PubMed ID: 4966768
    [No Abstract]   [Full Text] [Related]  

  • 29. [Virulence and catalase activity of isoniazid-resistant human tubercle bacilli].
    TAKAHASHI Y; KUZE A; ARIMA J; YAMAMOTO K
    C R Seances Soc Biol Fil; 1956; 150(10):1837-40. PubMed ID: 13414335
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of ultraviolet irradiation on the acid-fastness of drug-resistant mutants of tubercle bacilli, with special reference to the virulence of isoniazid-resistant strains.
    Murohashi T; Yoshida K
    Am Rev Respir Dis; 1968 Feb; 97(2):283-91. PubMed ID: 4966163
    [No Abstract]   [Full Text] [Related]  

  • 31. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis.
    Zhang Y; Heym B; Allen B; Young D; Cole S
    Nature; 1992 Aug; 358(6387):591-3. PubMed ID: 1501713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A clinical study on the virulence of INH-resistant tubercle bacilli in the human body].
    Murata A
    Kekkaku; 1967 Aug; 42(8):309-11. PubMed ID: 4966678
    [No Abstract]   [Full Text] [Related]  

  • 33. [Catalase activity of drug-resistant Mycobacterium tuberculosis strains].
    Smirnov VD
    Antibiotiki; 1971 Oct; 16(10):917-9. PubMed ID: 5003057
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparative study of enzymatic activities of new KatG mutants from low- and high-level isoniazid-resistant clinical isolates of Mycobacterium tuberculosis.
    Brossier F; Boudinet M; Jarlier V; Petrella S; Sougakoff W
    Tuberculosis (Edinb); 2016 Sep; 100():15-24. PubMed ID: 27553406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Catalase and peroxydase activity of INH-sensitive and INH-resistant strains of tuberculosis bacilli (human type) isolated from surgical and autopsy material].
    Dorn M
    Beitr Klin Erforsch Tuberk Lungenkr; 1965 Dec; 131(4):300-14. PubMed ID: 4956561
    [No Abstract]   [Full Text] [Related]  

  • 36. [Study of isoniazid-resistant tubercle bacilli. I. On the population change of isoniazid-resistant tubercle bacilli as regards their resistance to isoniazid].
    NAGASHIMA M
    Kekkaku; 1960 Dec; 35():861-7. PubMed ID: 13727413
    [No Abstract]   [Full Text] [Related]  

  • 37. [Therapeutic and epidemiological significance of the virulence of isoniazid-resistant bacteria].
    GECZY-NAGY A
    Tuberkulozis; 1957; 10(10-12):241-3. PubMed ID: 13557023
    [No Abstract]   [Full Text] [Related]  

  • 38. [Studies on the infection of drug-resistant tubercle bacilli. 3. Experimental studies on the infection of INH highly-resistant tubercle bacilli].
    Osato T; Toyohara M; Aoki M; Hatori H
    Kekkaku; 1968 Nov; 43(11):473-9. PubMed ID: 4975533
    [No Abstract]   [Full Text] [Related]  

  • 39. [Examination of resected lung preparations. I. The effect of isoniazid treatment on isoniazid resistance and virulence destruction of Mycobacteria tuberculosis; bacteriologic examination].
    KRACHT J; MEISSNER G
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1956; 116(2):144-57. PubMed ID: 13373711
    [No Abstract]   [Full Text] [Related]  

  • 40. Mutations in catalase-peroxidase KatG from isoniazid resistant Mycobacterium tuberculosis clinical isolates: insights from molecular dynamics simulations.
    Pimentel AL; de Lima Scodro RB; Caleffi-Ferracioli KR; Siqueira VL; Campanerut-Sá PA; Lopes LD; de Almeida AL; Cardoso RF; Seixas FA
    J Mol Model; 2017 Apr; 23(4):121. PubMed ID: 28303436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.